Wave Life Sciences WVE SG — Deferred Income Tax Expense Benefit
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The official record: Wave Life Sciences’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's sg — deferred income tax expense benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Wave Life Sciences's SG — deferred income tax expense benefit?
- Wave Life Sciences (WVE) reported SG — deferred income tax expense benefit of $0 in Q4 2025.
- What does SG — deferred income tax expense benefit mean?
- Captures the tax effects of temporary differences between the financial reporting and tax bases of assets and liabilities within the segment. This metric indicates future tax obligations or benefits that will materialize as these differences reverse.